KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

Stock Information for KORU Medical Systems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About KORU Medical Systems Inc.

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance
KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference
KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan
Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion
KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.